Kerecis ehf:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Kerecis ehf - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10920
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイスランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kerecis ehf (Kerecis) is a medical device company that provides products that treats chronic wounds and damaged tissue. The company’s flagship product includes Kerecis Omega3 fish-skin acellular dermal matrix transplantation technology is intended for use in products to treat acute, chronic and oral wounds, for dura mater repair, breast reconstruction and abdominal wall reconstruction and for surgical stapling. It also develops mOmega3 fatty acid (fish-sourced fatty acids) technology for use in several dermatological indications such as psoriasis, eczema, dermatitis, keratosis pilaris and pseudofolliculitis. Kerecis also provides fish-skin acellular dermal matrix products including Omega3 Wound, Omega3 Dura, Omega3 Hernia, Omega3 Pectus, Omega3 Seal, and topical creams including Smooth with mOmega3, Footguard with mOmega3, Psoria with mOmega3 and Xma with mOmega3. The company uses complete acellular fish skin for tissue regeneration by transplantation. It operates through its offices in Isafjordur and Reykjavik, Iceland. Kerecis is headquartered in Isafjordur, Iceland.

Kerecis ehf – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kerecis ehf, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kerecis ehf, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kerecis ehf, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kerecis ehf, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kerecis ehf, Medical Devices Deals, 2012 to YTD 2018 9
Kerecis ehf, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kerecis ehf, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Kerecis Raises US$2 Million In Series A3 Financing 11
Kerecis Raises US$1 Million In A2 Financing 13
Partnerships 14
Kerecis Enters into Co-Development Agreement with Office of Naval Research 14
Kerecis Enters Into Distribution Agreement With Medline Industries For MariGen Omega3 Regenerative Technology 15
Kerecis ehf – Key Competitors 16
Kerecis ehf – Key Employees 17
Kerecis ehf – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Nov 06, 2017: Kerecis Expands Scientific Advisory Board 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Kerecis ehf, Pharmaceuticals & Healthcare, Key Facts 2
Kerecis ehf, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kerecis ehf, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kerecis ehf, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kerecis ehf, Deals By Therapy Area, 2012 to YTD 2018 8
Kerecis ehf, Medical Devices Deals, 2012 to YTD 2018 9
Kerecis ehf, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kerecis Raises US$2 Million In Series A3 Financing 11
Kerecis Raises US$1 Million In A2 Financing 13
Kerecis Enters into Co-Development Agreement with Office of Naval Research 14
Kerecis Enters Into Distribution Agreement With Medline Industries For MariGen Omega3 Regenerative Technology 15
Kerecis ehf, Key Competitors 16
Kerecis ehf, Key Employees 17
Kerecis ehf, Other Locations 18

List of Figures
Kerecis ehf, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kerecis ehf, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kerecis ehf, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kerecis ehf, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Kerecis ehf, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kerecis ehf, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kerecis ehf, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kerecis ehf, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Kerecis ehf, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Kerecis ehf:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Gramercy Property Trust Inc.:企業のM&A・提携・投資分析
    Gramercy Property Trust Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gramercy Property Trust Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • HORNBACH Holding AG & Co. KGaA:企業の戦略・SWOT・財務情報
    HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • NARI Technology Development Co Ltd (600406):企業の財務・戦略的SWOT分析
    NARI Technology Development Co Ltd (600406) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Mega Financial Holding Co., Ltd.:企業の戦略・SWOT・財務情報
    Mega Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mega Financial Holding Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • 4SC AG (VSC):企業のM&A・提携動向(医療分野)
    Summary 4SC AG (4SC) discovers and develops small molecule drugs for the treatment of cancer and autoimmune diseases. The company’s product focuses on epigenetics, cancer stem cells and cancer immunotherapy. Its product pipeline comprises therapeutic programs at various stages of clinical developmen …
  • Fate Therapeutics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Fate Therapeutics, Inc. Mergers …
  • Harakosan Co., Ltd. (8894):企業財務及び戦略的SWOT分析
    Summary Harakosan Co., Ltd. (Harakosan) is a construction company that provides real estate, construction and business environment services. The company offers services such as condominiums for sale, condominium sales agency, living space development, rental housing mediation and management, among o …
  • TRUenergy Pty., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TRUenergy Pty., Ltd. Mergers an …
  • Medidata Solutions Inc (MDSO):企業のM&A・提携動向(医療機器分野)
    Summary Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data & analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analy …
  • Globe Telecom, Inc.:企業の戦略・SWOT・財務情報
    Globe Telecom, Inc. - Strategy, SWOT and Corporate Finance Report Summary Globe Telecom, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CMS Energy Corporation (CMS):企業のM&A・提携動向(発電分野)
    Summary CMS Energy Corporation (CMS Energy) is an energy utility company that provides utility services related to natural gas and electricity. It offers gas and electricity services through its subsidiaries, namely, Consumers Energy (Consumers) and CMS Enterprises. Consumers is an electric and gas …
  • Intel Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Intel Corporation Mergers and A …
  • Amobee, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Amobee, Inc. Mergers and Acquis …
  • The Boston Consulting Group:企業の戦略的SWOT分析
    The Boston Consulting Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Emsland Group:企業の戦略・SWOT・財務分析
    SummaryEmsland Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • KBC Group NV:企業のM&A・提携・投資分析
    KBC Group NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KBC Group NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Leroy Seafood Group ASA:企業の戦略・SWOT・財務情報
    Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report Summary Leroy Seafood Group ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • U.S. HealthWorks Medical Group-製薬・医療分野:企業M&A・提携分析
    Summary U.S. HealthWorks Medical Group (U.S. HealthWorks), a subsidiary of Dignity Health is a healthcare service provider that offers physical therapy, rehabilitation and medical review. The center’s services include occupational medicine, urgent care, specialty care and therapy services. Its occup …
  • Sanchuan Wisdom Technology Co., Ltd. (300066):企業財務及び戦略的SWOT分析
    Summary Sanchuan Wisdom Technology Co., Ltd. (Sanchuan), formerly Jiangxi Sanchuan Water Meter Co., Ltd. is a clean technology company that manufactures and markets water meters. The company offers products, which include intelligent card type water meters, stainless steel water meters, H4000P, phot …
  • Gildan Activewear Inc (GIL):企業の財務・戦略的SWOT分析
    Gildan Activewear Inc (GIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆